Updated Jul 16, 2026
SULIMAN SHEHNAAZ has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $331K.

Shehnaaz Suliman is a professional listed in Ultragenyx Pharmaceutical Inc.'s SEC filings as of May 18, 2026. Public SEC documentation associated with Ultragenyx at that date does not publicly disclose her official title, tenure, or detailed professional background. The available SEC context does not provide a comprehensive biography, so her exact role (e.g., officer, director, or other affiliated personnel) remains unspecified in the filings.
| Role | Insider |
|---|---|
| Notability | 15/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-18 | TXG | 10x Genomics, Inc. | S — Open-market sale | 364 | $33.27 | $12K |
| 2026-06-18 | TXG | 10x Genomics, Inc. | S — Open-market sale | 5.4K | $32.59 | $175K |
| 2026-06-08 | TXG | 10x Genomics, Inc. | A — Grant or award | 8.8K | $0.00 | |
| 2026-05-18 | RARE | Ultragenyx Pharmaceutical Inc. | S — Open-market sale | 5.7K | $25.12 | $144K |
| 2026-05-18 | RARE | Ultragenyx Pharmaceutical Inc. | A — Grant or award | 7.8K | $0.00 |
Shehnaaz Suliman is a professional listed in Ultragenyx Pharmaceutical Inc.'s SEC filings as of May 18, 2026. Public SEC documentation associated with Ultragenyx at that date does not publicly disclose her official title, tenure, or detailed professional background. The available SEC context does not provide a comprehensive biography, so her exact role (e.g., officer, director,…
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($331K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live SULIMAN SHEHNAAZ profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.